Procept Biorobotics: Revolution in Urology and a 10 Million Dollar Signal to the Markets
Reading Time: 2 minutes
Procept Biorobotics (PRCT) is revolutionizing urology with surgical robotics. The core product is the Aquablation therapy, performed using the AquaBeam and HYDROS systems. This technology enables a minimally invasive, heat-free treatment of benign prostatic hyperplasia (BPH). Through real-time imaging and automated water jet ablation, tissue is removed with high precision. For the company, this represents a paradigm shift that shortens surgery times and minimizes side effects. In the future, this technology is expected to become the standard for...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
